Health Canada drug identification number

DIN 02242473 — ATRIDOX 8.8 %

ATRIDOX is a gel (controlled-release) of Doxycycline marketed by DEN-MAT HOLDINGS, LLC. The full Doxycycline monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02242473
Brand name
ATRIDOX
Active ingredient
Doxycycline
Strength
8.8 %
Dosage form
GEL (CONTROLLED-RELEASE)
Route
SUBGINGIVAL
Manufacturer
DEN-MAT HOLDINGS, LLC
Health Canada status
DORMANT
Drug class
Tetracycline antibiotic

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Doxycycline products

DINBrandStrengthFormManufacturerStatus
02556928 AG-DOXYCYCLINE 100 MG TABLET ANGITA PHARMA INC. MARKETED
00874256 APO-DOXY-TABS 100 MG TABLET APOTEX INC MARKETED
00860751 DOXYCIN TAB 100MG 100 MG TABLET LABORATOIRE RIVA INC. MARKETED
02351242 DOXYCYCLINE TABLETS 100 MG TABLET SANIS HEALTH INC DORMANT
00887064 DOXYTAB 100 MG TABLET PRO DOC LIMITEE MARKETED
02554372 JAMP DOXYCYCLINE TABLETS 100 MG TABLET JAMP PHARMA CORPORATION MARKETED
02543478 M-DOXYCYCLINE 100 MG TABLET MANTRA PHARMA INC MARKETED
02558505 NRA-DOXYCYCLINE 100 MG TABLET NORA PHARMA INC MARKETED
02536250 PRZ-DOXYCYCLINE 100 MG TABLET PHARMARIS CANADA INC MARKETED
02158574 TEVA-DOXYCYCLINE 100 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.